000140876 001__ 140876
000140876 005__ 20240229105118.0
000140876 037__ $$aDKFZ-2018-01631
000140876 1001_ $$0P:(DE-He78)cd7eb75e4b89ac0b520b75c4f63b272f$$aShen, Jing$$b0$$gnot specified$$udkfz
000140876 245__ $$aTargeted Therapy of Neuroblastoma with HDAC8 Inhibitor and ALK Inhibitor.
000140876 260__ $$c2018
000140876 3367_ $$2DataCite$$aOutput Types/Dissertation
000140876 3367_ $$2ORCID$$aDISSERTATION
000140876 3367_ $$2BibTeX$$aPHDTHESIS
000140876 3367_ $$02$$2EndNote$$aThesis
000140876 3367_ $$0PUB:(DE-HGF)11$$2PUB:(DE-HGF)$$aDissertation / PhD Thesis$$bphd$$mphd$$s1540556981_23542
000140876 3367_ $$2DRIVER$$adoctoralThesis
000140876 502__ $$aDissertation, Universität Heidelberg, 2018$$bDissertation$$cUniversität Heidelberg$$gMedizinische Fakultät
000140876 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000140876 909CO $$ooai:inrepo02.dkfz.de:140876$$pVDB
000140876 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)cd7eb75e4b89ac0b520b75c4f63b272f$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000140876 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000140876 9141_ $$y2018
000140876 9201_ $$0I:(DE-He78)G340-20160331$$kG340$$lKKE Pädiatrische Onkologie$$x0
000140876 980__ $$aphd
000140876 980__ $$aVDB
000140876 980__ $$aI:(DE-He78)G340-20160331
000140876 980__ $$aUNRESTRICTED